Monographie - Filgrastim - Stabilis 4.0

zadnja posodobitev :
19/11/2024

Različen

Filgrastim

Brizgalka

Stabilnost raztopine

Stabilnost mešanice

Faktorji, ki vplivajo na stabilnost

Kompatibilnost

način aplikacije

Viri

pdf

Lastniško ime

Lastniško ime

Sestava pomožnih snovi je med paralelami lahko različna

Accofil	Belgija, Nemčija, Velika Britanija
Biocilin	Mehika
Duperan	Čile
Filgen	Argentina
Foltran	Čile
Granulokine	Grčija, Italija
Hebervital	Kolumbija
Inmunef	Kolumbija
Leucosos	Kolumbija
Lioplim	Čile
Neupogen	Avstrija, Belgija, Danska, Finska, Francija, Hrvaška, Južnoafriška republika, Nizozemska, Poljska, Portugalska, Slovenija, Španija, Švedska, Švica, Turčija, Velika Britanija, Združene države Amerike
Neutromax	Argentina
Neutropine	Argentina
Nivestim	Belgija, Francija, Nemčija, Nizozemska, Norveška, Velika Britanija
Ratiograstim	Avstrija, Nemčija, Švedska, Velika Britanija
Tevagrastim	Nemčija, Nizozemska, Norveška, Švedska, Švica, Velika Britanija

Viri

Brizgalka

Viri : Filgrastim

	Tip	objava
99	časopis	Trissel LA, Martinez JF. Compatibility of aztreonam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
104	časopis	Hall PD, Yui D, Lyons S, Bosso JA. Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 185-189.
182	časopis	Trissel LA, Gilbert DL, Martinez JF. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 56-60.
244	časopis	Trissel LA, Martinez JF. Compatibility of filgrastim with selected drugs during simulated Y-site administration. Am J Hosp Pharm 1994 ; 51: 1907-1913.
2269	časopis	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3128	Traduction Laboratorij	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit Prostrakan 2013
3249	časopis	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3256	časopis	Burnett B, Radic I. Stability of Hospira filgrastim following changes to thermal and photic storage conditions. EJHP 2011 ; 17, 5: 49-56.
3474	Traduction Laboratorij	Fluorouracil - Summary of Product Characteristics Accord Healthcare Limited 2009
3618	Traduction Laboratorij	Filgrastim (Neupogen®) - Summary of Product Characteristics Amgen 2014
3828	poster	Thabit A.K, Hamada Y, Nicolau D.P. Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. ASHP Midyear 2015
3829	poster	So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L. Compatibility of isavunazonium sulfate during simulated Y-site administration. ASHP Midyear 2015
4055	časopis	Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D. Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Am J Health-Syst Pharm 2018 , 75, 1:36-44
4380	Traduction Laboratorij	Posaconazole (Noxafil®) - Summary of Product Characteristics Merck Sharp & Dohme Limited 2019
4471	Traduction Laboratorij	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019 Kyowa Kirin Pharma 2019
4521	časopis	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4650	Traduction Laboratorij	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales